Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Non-Current Deferred Tax Liability (2022 - 2025)

Historic Non-Current Deferred Tax Liability for Cartesian Therapeutics (RNAC) over the last 4 years, with Q3 2025 value amounting to $16.1 million.

  • Cartesian Therapeutics' Non-Current Deferred Tax Liability rose 181.67% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year increase of 181.67%. This contributed to the annual value of $16.1 million for FY2024, which is 6333.51% down from last year.
  • Per Cartesian Therapeutics' latest filing, its Non-Current Deferred Tax Liability stood at $16.1 million for Q3 2025, which was up 181.67% from $16.1 million recorded in Q2 2025.
  • Cartesian Therapeutics' 5-year Non-Current Deferred Tax Liability high stood at $44.0 million for Q4 2023, and its period low was $3.3 million during Q4 2022.
  • Over the past 4 years, Cartesian Therapeutics' median Non-Current Deferred Tax Liability value was $16.1 million (recorded in 2024), while the average stood at $17.7 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first soared by 125247.31% in 2023, then crashed by 6333.51% in 2024.
  • Cartesian Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $3.3 million in 2022, then soared by 1252.47% to $44.0 million in 2023, then crashed by 63.34% to $16.1 million in 2024, then changed by 0.0% to $16.1 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $16.1 million for Q3 2025, versus $16.1 million for Q2 2025 and $16.1 million for Q1 2025.